Literature DB >> 33882227

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. Reply.

Noam Barda1, Noa Dagan1, Ran D Balicer1.   

Abstract

Entities:  

Year:  2021        PMID： 33882227     DOI： 10.1056/NEJMc2104281

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  15 in total

1.  Indirect Protection by Reducing Transmission: Ending the Pandemic With Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination.

Authors:  Aaron Richterman; Eric A Meyerowitz; Muge Cevik
Journal:  Open Forum Infect Dis       Date:  2021-05-19       Impact factor: 3.835

2.  Nephrotic Syndrome After Vaccination Against COVID-19: Three New Cases From Germany.

Authors:  Harald Dormann; Anja Knüppel-Ruppert; Kerstin Amann; Christiane Erley
Journal:  Dtsch Arztebl Int       Date:  2021-10-01       Impact factor: 5.594

3.  Superior immunogenicity and effectiveness of the third compared to the second BNT162b2 vaccine dose.

Authors:  Yaniv Lustig; Tal Gonen; Lilac Meltzer; Mayan Gilboa; Victoria Indenbaum; Carmit Cohen; Sharon Amit; Hanaa Jaber; Ram Doolman; Keren Asraf; Carmit Rubin; Ronen Fluss; Ella Mendelson; Laurence Freedman; Gili Regev-Yochay; Yitshak Kreiss
Journal:  Nat Immunol       Date:  2022-05-09       Impact factor: 31.250

Review 4.  The burden and risks of emerging complications of diabetes mellitus.

Authors:  Dunya Tomic; Jonathan E Shaw; Dianna J Magliano
Journal:  Nat Rev Endocrinol       Date:  2022-06-06       Impact factor: 47.564

5.  COVID-19 and the intensive care unit: vaccines to the rescue.

Authors:  Kai Dallmeier; Geert Meyfroidt; Johan Neyts
Journal:  Intensive Care Med       Date:  2021-05-25       Impact factor: 17.440

6.  Diminished and waning immunity to COVID-19 vaccination among hemodialysis patients in Israel: the case for a third vaccine dose.

Authors:  Avital Angel-Korman; Esther Peres; Gabriel Bryk; Yaniv Lustig; Victoria Indenbaum; Sharon Amit; Vladimir Rappoport; Zeev Katzir; Yoram Yagil; Nomy Levin Iaina; Adi Leiba; Tal Brosh-Nissimov
Journal:  Clin Kidney J       Date:  2021-10-12

7.  BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel.

Authors:  Tal Brosh-Nissimov; Efrat Orenbuch-Harroch; Michal Chowers; Meital Elbaz; Lior Nesher; Michal Stein; Yasmin Maor; Regev Cohen; Khetam Hussein; Miriam Weinberger; Oren Zimhony; Bibiana Chazan; Ronza Najjar; Hiba Zayyad; Galia Rahav; Yonit Wiener-Well
Journal:  Clin Microbiol Infect       Date:  2021-07-07       Impact factor: 8.067

8.  Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients With CKD.

Authors:  Edward J Carr; Andreas Kronbichler; Matthew Graham-Brown; Graham Abra; Christos Argyropoulos; Lorraine Harper; Edgar V Lerma; Rita S Suri; Joel Topf; Michelle Willicombe; Swapnil Hiremath
Journal:  Kidney Int Rep       Date:  2021-07-06

Review 9.  Gastrointestinal and hepatic side effects of potential treatment for COVID-19 and vaccination in patients with chronic liver diseases.

Authors:  Man Fai Law; Rita Ho; Kimmy Wan Tung Law; Carmen Ka Man Cheung
Journal:  World J Hepatol       Date:  2021-12-27

10.  Protected or not protected, that is the question - First data on COVID-19 vaccine responses in patients with NAFLD and liver transplant recipients.

Authors:  Markus Cornberg; Christiane S Eberhardt
Journal:  J Hepatol       Date:  2021-05-25       Impact factor: 25.083
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.